In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TRADE AND EXECUTIVE CHANGES IN OTC DRUG BUSINESS

This article was originally published in The Tan Sheet

Executive Summary

TRADE AND EXECUTIVE CHANGES IN OTC DRUG BUSINESS are affecting the way the Nonprescription Drug Manufacturers Association perceives its relationship to its membership and its functions, the association management indicated in presentations at the May 15-16 annual meeting. "To meet a growing need" related to executive changes in the OTC industry, NDMA Chairman David Collins (Schering-Plough) said, the association will "soon begin a series of training seminars for personnel new to a company or new to the issues of the industry."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel